PRLD
insider transactionsPrelude Therapeutics Inc — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
+3.5M
3.5M buy · 0 sell
Net value · 90d
$12.5M
$12.5M in · $0 out
Sentiment · 90d
Net buying
100% buying · 0% selling
Open-market trades · 90d
4
3.5M buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
15.6K sh
Own New
-
Grant·A
Director
$0
38.0K sh
Own New
-
Grant·A
Director
$0
38.0K sh
Own New
-
Grant·A
Director, 10% Owner
$0
38.0K sh
Own New
-
Grant·A
Director
$0
38.0K sh
Own New
-
Grant·A
Chief Medical Officer
$2.1M
450.0K sh · $4.70
Own New
-
Buy·P
Director, 10% Owner
$5.0M
1.1M sh · $4.44
Own New
-
Buy·P
Director, 10% Owner
$7.5M
1.7M sh · $4.44
Own +17%
-
Buy·P
Director
—
384.7K sh
Own New
-
Buy·P
Director
—
336.6K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | David P Bonita | Grant A | 15.6K | $0 |
| Jun 9, 2026 | Victor Sandor | Grant A | 38.0K | $0 |
| Jun 9, 2026 | Paul A Friedman | Grant A | 38.0K | $0 |
| Jun 9, 2026 | David P Bonita | Grant A | 38.0K | $0 |
| Jun 9, 2026 | Martin Babler | Grant A | 38.0K | $0 |
| May 1, 2026 | Charles Q Morris | Grant A | 450.0K | $2.1M |
| Apr 21, 2026 | David P Bonita | Buy P | 1.1M | $5.0M |
| Apr 21, 2026 | David P Bonita | Buy P | 1.7M | $7.5M |
| Apr 14, 2026 | David P Bonita | Buy P | 384.7K | — |
| Apr 14, 2026 | David P Bonita | Buy P | 336.6K | — |
About PRLD insider trading
This page tracks insider transactions for Prelude Therapeutics Inc (PRLD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.